Ann: Medgate extends licence agreement and plans to expand use, page-16

Why does it feel like RAP suppressed all these announcements to the market when they were negotiating with Pfizer.

It would have dramatically helped out our valuation.... and also how much of this was information was taken into account with the IER when they came up with fair value (or were these finer points not shared with the IER?)

Doesn't anybody else feel like that's suss?

The BOD are sleeping with Pfizer and trying to screw over SH.